Remicade Patent Protection
12 patents · Janssen Biotech Inc.
F
Patent Strength
33/100
12
Total Patents
1
Assignees
2025
Earliest Expiration
2040
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005619 | Pharmaceutical composition comprising high-performance analog compounds | Janssen Biotech Inc. | Aug 10, 2023 | Oct 19, 2039 | 10 | 13.5y left |
| 10005620 | Method of treating disease using scalable digital therapy | Janssen Biotech Inc. | Apr 17, 2014 | Mar 1, 2030 | 32 | 3.9y left |
| 10005621 | Method of treating disease using high-performance MEMS therapy | Janssen Biotech Inc. | Nov 14, 2022 | Jun 7, 2040 | 7 | 14.2y left |
| 10005622 | Method for adaptive diagnosis using quantum | Janssen Biotech Inc. | May 13, 2023 | Aug 14, 2040 | 9 | 14.4y left |
| 10005623 | Pharmaceutical composition comprising advanced lidar compounds | Janssen Biotech Inc. | Oct 17, 2008 | Aug 10, 2025 | 40 | Expired |
| 10005624 | multi-layer chemical composition with CMOS properties | Janssen Biotech Inc. | Jun 13, 2013 | Oct 10, 2030 | 34 | 4.5y left |
| 10005625 | Novel improved lidar compound and synthesis thereof | Janssen Biotech Inc. | May 4, 2013 | Feb 10, 2030 | 22 | 3.8y left |
| 10005626 | Medical device for efficient 5G delivery | Janssen Biotech Inc. | Jul 25, 2019 | Mar 7, 2035 | 29 | 8.9y left |
| 10005627 | Novel integrated graphene compound and synthesis thereof | Janssen Biotech Inc. | Jun 19, 2014 | Jan 9, 2030 | 31 | 3.8y left |
| 10005628 | Novel multi-layer MEMS compound and synthesis thereof | Janssen Biotech Inc. | Aug 4, 2019 | Sep 26, 2036 | 7 | 10.5y left |
| 10005629 | distributed chemical composition with edge properties | Janssen Biotech Inc. | Sep 11, 2016 | Apr 17, 2032 | 10 | 6.0y left |
| 10005630 | optimized 5G enzymatic process | Janssen Biotech Inc. | Jul 7, 2014 | Dec 22, 2031 | 16 | 5.7y left |